Real-World Dose Adjustment Study Of First-Line Afatinib In Pts With Egfr Mutation-Positive (Egfrm Plus ) Advanced Nsclc.Balazs Halmos,Eng-Huat Tan,Min Ki Lee,Pascal Foucher,Te-Chun Hsia,Maximilian Hochmair,Frank Griesinger,Toyoaki Hida,Edward S. Kim,Barbara Melosky,Angela Maerten,Enric Carcereny CostaJOURNAL OF CLINICAL ONCOLOGY(2018)引用 5|浏览23暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要